Global regulatory collaboration for the assessment of lenacapavir as a long-acting pre-exposure prophylaxis against HIV infection. [PDF]
Front Public HealthKristyanto H +5 more
europepmc +1 more source
Pre-exposure and Post-exposure prophylaxis for dog bites
African Journal of Paediatric Surgery, 2017 Beuy Joob, Viroj Wiwanitkit
doaj +1 more source
Indirect Treatment Comparison of Long-Acting Injectable Cabotegravir as Pre-exposure Prophylaxis When Compared with no Pre-exposure Prophylaxis for HIV Prevention. [PDF]
Infect Dis TherHawkins N +6 more
europepmc +1 more source
Vaginal dysbiosis and pre-exposure prophylaxis efficacy
The Lancet HIV, 2017 van de Wijgert, Janneke +1 more
openaire +3 more sources
An exploratory study of physicians' familiarity, knowledge, and willingness to prescribe pre-exposure prophylaxis in the MENA region. [PDF]
Sci RepNaous J +5 more
europepmc +1 more source
Missed opportunities to prescribe HIV pre-exposure prophylaxis by primary care providers in Saint Louis, Missouri [PDF]
, 2018 Chan, Philip A +6 more
core +2 more sources
Changes in geographic drive time access to pre-exposure prophylaxis (PrEP) in the United States, 2017 to 2025. [PDF]
Prev Med RepMancuso N +3 more
europepmc +1 more source
The Current and Future Impact of WHO Guidance on Global HIV Pre-Exposure Prophylaxis Programs: A Narrative Review. [PDF]
Infect Drug ResistMishriky F, Chan PA.
europepmc +1 more source